Quick Answer
PALVELLA THERAPEUTICS, INC. reported Stockholders Equity of $27.98 million for fiscal year 2025.
PALVELLA THERAPEUTICS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $27.98M | -55.3% |
| 2024 | $62.61M | +184.1% |
| 2023 | -$74.48M | +20.6% |
| 2022 | -$93.78M | -284.8% |
| 2021 | $50.76M | +63.6% |
| 2020 | $31.03M | -39.6% |
| 2019 | $51.35M | +28.6% |
| 2018 | $39.94M | +246.6% |
| 2017 | $11.52M | -54.3% |
| 2016 | $25.23M | -19.0% |
| 2015 | $31.13M | +72.9% |
| 2014 | $18.01M | +179712.4% |
| 2014 | $10.0K | -98.3% |
| 2013 | $585.0K | +12278.5% |
| 2013 | $4.7K | -99.0% |
| 2012 | $495.7K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $38.68M | +144.3% | -19.0% |
| June 30, 2025 | $47.78M | +159.1% | -14.0% |
| March 31, 2025 | $55.58M | +172.3% | -11.2% |
| December 31, 2024 | $62.61M | +184.1% | +171.6% |
| September 30, 2024 | -$87.40M | -386.5% | -8.1% |
| June 30, 2024 | -$80.83M | -299.6% | -5.1% |
| March 31, 2024 | -$76.87M | -597.3% | -3.2% |
| December 31, 2023 | -$74.48M | -366.7% | -344.1% |
- PALVELLA THERAPEUTICS, INC. showed a decrease of -55.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 2012–2025 period, PALVELLA THERAPEUTICS, INC.’s stockholders equity has grown by 5545.1% (from $495.7 thousand to $27.98 million).
- The most recent figure is from PALVELLA THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: